Re: LRMR: Tanking on Phase II topline results
I can't believe people are that excited by these results, but one Twitter post dropped it 40%.
They will have to raise capital soon and they are entering a dead-zone until next readout. Wouldn't be surprised if we see a secondary in the days ahead.
Couple red-flags from the readout:
- it is a multi-ascending does trial, and they are adding another dose schedule. That's going to lengthen the trial time and cause further need for capital
- LRMR was killing non-human primates earlier. Higher doses increases the risk of a sudden negative event here.